Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
STERIS approves an additional targeted restructuring plan
STERIS approved an additional targeted restructuring plan during the quarter, involving facility realignment, product rationalization and selected organizational realignment, primarily in its Healthcare segment. The company anticipates approximately $45 million in charges and approximately $9 million in annualized savings.
2021
STERIS reports fiscal 2022 first-quarter results
STERIS reported fiscal 2022 first-quarter financial results, including revenue growth and segment results.
2021
STERIS raises fiscal 2022 outlook
STERIS raised its fiscal 2022 revenue, organic growth and adjusted earnings expectations.
2021
STERIS announces CEO succession plan
STERIS announced that Walt Rosebrough intends to step down as CEO on July 29, 2021, and that Chief Operating Officer Dan Carestio will succeed him as President and CEO on that date.